Curaxin CBL0137 eradicates drug resistant cancer stem cells and potentiates efficacy of gemcitabine in preclinical models of pancreatic cancer

por Burkhart, Catherine, Fleyshman, Daria, Kohrn, Rachael, Commane, Mairead, Garrigan, Jennifer, Kurbatov, Vadim, Toshkov, Ilya, Ramachandran, Rajesh, Martello, Laura, Gurova, Katerina V.
Publicado 2014

TRAIN (Transcription of Repeats Activates INterferon) in response to chromatin destabilization induced by small molecules in mammalian cells

por Leonova, Katerina, Safina, Alfiya, Nesher, Elimelech, Sandlesh, Poorva, Pratt, Rachel, Burkhart, Catherine, Lipchick, Brittany, Gitlin, Ilya, Frangou, Costakis, Koman, Igor, Wang, Jianmin, Kirsanov, Kirill, Yakubovskaya, Marianna G, Gudkov, Andrei V, Gurova, Katerina
Publicado 2018

A deimmunized and pharmacologically optimized Toll-like receptor 5 agonist for therapeutic applications

por Mett, Vadim, Kurnasov, Oleg V., Bespalov, Ivan A., Molodtsov, Ivan, Brackett, Craig M., Burdelya, Lyudmila G., Purmal, Andrei A., Gleiberman, Anatoli S., Toshkov, Ilia A., Burkhart, Catherine A., Kogan, Yakov N., Andrianova, Ekaterina L., Gudkov, Andrei V., Osterman, Andrei L.
Publicado 2021